Growth Hormone for the Treatment of Gastroparesis
Growth Hormone for the Treatment of Gastroparesis
Recruiting · NCT06803589 · Registry updated 2026-04-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Growth Hormone for the Treatment of Gastroparesis | Digestive System Diseases, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, digestive system disorder, gastroparesis, palsy, stomach disorder | Recruiting | Early phase 1 | 2026-04-16 | NCT06803589 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Mayo Clinic | 970 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Mayo Clinic | Phoenix | United States | 50 |
| Mayo Clinic in Arizona | Scottsdale | United States | 191 |